Fortrea Holdings (FRA:K67) Change In Inventory : €0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Fortrea Holdings Change In Inventory?

Fortrea Holdings's change in inventory for the quarter that ended in Mar. 2024 was €0 Mil. It means Fortrea Holdings's inventory stayed the same from Dec. 2023 to Mar. 2024 .

Fortrea Holdings's change in inventory for the fiscal year that ended in Dec. 2023 was €0 Mil. It means Fortrea Holdings's inventory stayed the same from Dec. 2022 to Dec. 2023 .

Fortrea Holdings's Total Inventories for the quarter that ended in Mar. 2024 was €0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Fortrea Holdings's Days Inventory for the quarter that ended in Mar. 2024 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Fortrea Holdings's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.00.

Fortrea Holdings Change In Inventory Historical Data

The historical data trend for Fortrea Holdings's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortrea Holdings Change In Inventory Chart

Fortrea Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Fortrea Holdings Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial						-	-	-	-	-

Fortrea Holdings Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

Fortrea Holdings (FRA:K67) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Fortrea Holdings's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	509.864	*	365 / 4
	=	0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Fortrea Holdings's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	509.864	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Fortrea Holdings's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	609.132
	=	0.00

Fortrea Holdings Change In Inventory Related Terms

Thank you for viewing the detailed overview of Fortrea Holdings's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Fortrea Holdings (FRA:K67) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortrea Holdings Inc (FRA:K67) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

FTRE:USA

Address

8 Moore Drive, Durham, NC, USA, 27709

Website

https://www.fortrea.com

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Fortrea Holdings (FRA:K67) Headlines

No Headlines